CG
FLXN

Cutler Group’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Cutler Group’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-49
Closed – – 5768
2020
Q3 		$0 Buy
+49
New +$600 ﹤0.01% 5468
2020
Q1 		– Sell
-600
Closed -$12K – 4933
2019
Q4 		$12K Sell
600
-2,900
-83% -$48.9K ﹤0.01% 2563
2019
Q3 		$47K Sell
3,500
-2,000
-36% -$23.7K ﹤0.01% 1593
2019
Q2 		$67K Buy
5,500
+5,300
+2,650% +$61.1K 0.01% 1340
2019
Q1 		$2K Sell
200
-2,100
-91% -$28.1K ﹤0.01% 3533
2018
Q4 		$26K Buy
+2,300
New +$36.1K ﹤0.01% 1940
2018
Q2 		– Sell
-17,548
Closed -$455K – 5167
2018
Q1 		$393K Buy
17,548
+5,853
+50% +$143K 0.03% 507
2017
Q4 		$292K Buy
11,695
+11,195
+2,239% +$274K 0.01% 771
2017
Q3 		$12K Sell
500
-225
-31% -$5.29K ﹤0.01% 3676
2017
Q2 		$14K Sell
725
-3,219
-82% -$67K ﹤0.01% 3843
2017
Q1 		$106K Buy
3,944
+3,444
+689% +$70.3K ﹤0.01% 1681
2016
Q4 		$9K Sell
500
-13,992
-97% -$267K ﹤0.01% 4374
2016
Q3 		$283K Sell
14,492
-303
-2% -$5.13K 0.01% 953
2016
Q2 		$221K Buy
14,795
+6,795
+85% +$85.4K 0.01% 1053
2016
Q1 		$73K Buy
8,000
+2,100
+36% +$25.5K ﹤0.01% 1928
2015
Q4 		$113K Buy
+5,900
New +$102K 0.01% 1647

Other funds holding FLXN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

Cutler Group's FLXN Position: Q4 2020 in Review

Cutler Group sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2020, closing a stake of 49 shares.

Cutler Group first reported a position in FLXN in Q4 2015 and held it in 16 quarters. The position peaked at $393K in Q1 2018. 141 funds tracked by Wall St. Rank hold FLXN as of Q4 2020.

  • Cutler Group reported no remaining Flexion Therapeutics, Inc. position as of Q4 2020 after selling out during the quarter.
  • Cutler Group sold 49 Flexion Therapeutics, Inc. shares in Q4 2020.
  • Cutler Group first reported a position in Flexion Therapeutics, Inc. in Q4 2015 and held it in 16 quarters.
  • Cutler Group's Flexion Therapeutics, Inc. position peaked at $393K in Q1 2018.
  • 141 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2020.

Based on Cutler Group's 13F filing for Q4 2020, filed 21 Jan 2021.